Sabatolimab (anti-TIM-3)

製品コード：A2037         Batch: A203705

印刷

Sabatolimab (anti-TIM-3) (MBG453, NVP-MBG453) is a high-affinity, humanized IgG4 antibody targeting TIM-3 on the surface of T-cells.

製品説明

CAS No. 2252262-24-9
Formulation PBS Buffer, PH 7.4
Isotype Human IgG4, κ
Application Sabatolimab (anti-TIM-3)
Source CHO cells
Storage
(From the date of receipt)		 Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles.
Shipping Shipped under low temperature conditions
Purity 99.17%
Protein concentration 5.1mg/ml
Endotoxin Level <2 EU/mg

カスタマーフィードバック

A2037-Sabatolimab-anti-TIM-3.gif

Selleckの高級品が、幾つかの出版された研究調査結果（以下を含む）で使われた：

Retinoic acid enhances γδ T cell cytotoxicity in nasopharyngeal carcinoma by reversing immune exhaustion [ Cell Commun Signal, 2025, 23(1):156] PubMed: 40158172
Human papillomavirus-encoded circular RNA circE7 promotes immune evasion in head and neck squamous cell carcinoma [ Nat Commun, 2024, 15(1):8609] PubMed: 39366979
Single-cell analysis of the survival mechanisms of fratricidal CAR-T targeting of T cell malignancies [ Mol Ther Nucleic Acids, 2024, 35(2):102225] PubMed: 38948332

人間や獣医の診断であるか治療的な使用のためにでない。